Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03292874 · ClinicalTrials.gov registry record · NA
High Resolution MRI Study for Prostate Cancer
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT03292874 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 64 participants.
The verdict
NCT03292874, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
This high resolution MRI (hrMRI), along with stand MRI (sMRI) will be obtained at baseline and again in approximately 1 year in patients on prostate cancer active surveillance. Changes in lesion size and ADC values will be assessed on the serial studies. This study evaluates the hypothesis that hrMRI will detect changes that sMRI cannot detect and that these changes will correlate with prostate cancer progression as determined on prostate biopsy.
Interventions
- DIAGNOSTIC_TEST high resolution MRI (hrMRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-09-13 |
| Est. Completion | 2022-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03292874
The ClinicalTrials.gov registry entry for NCT03292874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which high resolution MRI (hrMRI) is the first listed.
NCT03292874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03292874 about?
NCT03292874 is a clinical study titled "High Resolution MRI Study for Prostate Cancer". This high resolution MRI (hrMRI), along with stand MRI (sMRI) will be obtained at baseline and again in approximately 1 year in patients on prostate cancer active surveillance. Changes in lesion size and ADC values will be assessed on the serial studies. This study evaluates the hypothesis that hrMR...
What is the current status of trial NCT03292874?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2017-09-13. Estimated completion is 2022-12-14.
What interventions are being tested in trial NCT03292874?
The interventions under investigation include: high resolution MRI (hrMRI) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03292874?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.